Research Groups and R&D Platforms: Cancer
Research Group:
Computational Biomedicine and Bioinformatics
Laura Elo
laura.elo[at]utu.fi
Turku Bioscience Centre,
University of Turku
Autoimmune diseases, Bioinformatics, Biomarker, Biomedicine, Cancer, Cardiovascular diseases, Data mining, Diabetes, Diagnostics, Epigenomics, Genomics, Imaging, Machine learning, Metabolic diseases, Molecular diagnostics, Next-generation sequencing, Pattern recognition, Personalized medicine, Proteomics, Systems Biology, Target discovery
Research Group:
Data Mining and Modeling for Systems Biology and Pharmacology
Tero Aittokallio
tero.aittokallio[at]utu.fi
Department of Mathematics and Statistics,
University of Turku
Computational Systems Medicine
Bioinformatics, Biomarker, Biomedicine, Breast cancer, Cancer, Cardiovascular diseases, Computer Science, Data mining, Diabetes, Disease models, Drug target, Genomics, Imaging, Machine learning, Metabolic diseases, Natural Compounds, Natural products, Ovarian cancer, Pattern recognition, Personalized medicine, Pharmacology, Point of care, Prostate cancer, Proteomics, Screening, Signaling, Synthetic Biology, Systems Biology, Target discovery
Research Group:
BioNanoMaterials research group
Jessica Rosenholm
Jessica.rosenholm[at]abo.fi
Pharmaceutical Sciences Laboratory,
Åbo Akademi University
Pharmaceutical Sciences Laboratory
Antibacterial, Biomedicine, Biopharmaceuticals, Biotechnology, Cancer, Diagnostics, Drug delivery, Drug solubility, Drug stability, Electron microscopy, Fluorescence spectroscopy, Formulation, FTIR or RAMAN spectroscopy, Imaging software, Infection, Lead optimization, Musculoskeletal disorders, Nanoparticles, Natural products, Organic compounds, Particle morphology, Particle size analysis, Personalized medicine, Pharmacy, Physico-chemical properties, Porosity, Powder flow characterization, Powder X-ray diffraction, Preclinical development, Screening, Skin diseases, Super-resolution imaging, Surface area, Synthetic chemistry, Thermal analysis, Zeta potential
Research Group:
Structure and function of collagen receptor integrins
Jyrki Heino
jyrki.heino[at]utu.fi
Department of Life Technologies,
University of Turku
Basic research, Biochemistry, Biomedicine, Cancer, Disease models, Imaging, Infection, Inflammation, Molecular Cell Biology, Nanoparticles, Prostate cancer, Proteomics, Receptor, Signaling, Skin diseases, Structural Biology, Systems Biology, Target discovery, Virology
Research Group:
Functional Biomaterials & Microfluids
Hongbo Zhang
hongbo.zhang[at]abo.fi
Pharmaceutical Sciences Laboratory,
Åbo Akademi University
Structural Bioinformatics Laboratory
Atomic-force microscopy, Bioinformatics, Biomarker, Biomedicine, Cancer, Cardiovascular diseases, Data mining, Drug delivery, Drug solubility, Drug stability, Drug target, Electron microscopy, Fluorescence spectroscopy, FTIR or RAMAN spectroscopy, Genetics, Genomics, High throughput imaging, Imaging, Imaging software, In Vivo Diagnostics, Lead optimization, Molecular diagnostics, Nanoparticles, Next-generation sequencing, NMR, Nucleic acids, Organic compounds, Particle morphology, Particle size analysis, Personalized medicine, PET, Physico-chemical properties, Polymorph analysis, Porosity, Screening, Super-resolution imaging, Surface area, Synthetic chemistry, Target discovery, Thermal analysis, Ultrasound imaging, X-ray crystallography, Zeta potential
Research Group:
New tools to target harmful inflammations and cancer
Sirpa Jalkanen
sirjal[at]utu.fi
Institute of Biomedicine,
University of Turku
Cell Trafficking in Cancer and Inflammation
Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery
